Finance

Lists
688091:SHA
Shanghai Yizhong Pharmaceutical Co Ltd
CN¥35,04
+0,69%
(+0,24) 1D
15 Okt., 09:33:23 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688091...
Open
CN¥34,00
High
CN¥35,04
Low
CN¥33,80
Mkt. cap
7,40 mjd
Avg. vol.
2,80 m
Volume
309,60 k
P/E ratio
104,80
52-wk high
CN¥66,20
52-wk low
CN¥33,80
EPS
CN¥0,33
No. of employees
457
Open
CN¥34,00
High
CN¥35,04
Low
CN¥33,80
Mkt. cap
7,40 mjd
Avg. vol.
2,80 m
Volume
309,60 k
P/E ratio
104,80
52-wk high
CN¥66,20
52-wk low
CN¥33,80
EPS
CN¥0,33
No. of employees
457
News stories
From web sources and news partners
About Shanghai Yizhong Pharmaceutical Co Ltd
CEO-
Employees457
Founded10 Sep. 2009
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
82,82 m
72,95 m
79,16 m
86,68 m
Cost of goods sold
12,69 m
14,03 m
11,67 m
13,29 m
Cost of revenue
12,69 m
14,03 m
11,67 m
13,29 m
Research and development expenses
25,74 m
31,86 m
27,36 m
24,62 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
39,43 m
18,74 m
27,51 m
29,89 m
Operating expense
66,07 m
51,41 m
55,17 m
55,98 m
Total operating expenses
78,76 m
65,44 m
66,84 m
69,27 m
Operating income
4,06 m
7,51 m
12,32 m
17,41 m
Other non operating income
-1,06 m
1,06 m
-1,93 k
-1,23 k
EBT including unusual items
9,16 m
11,83 m
16,96 m
24,37 m
EBT excluding unusual items
7,11 m
12,82 m
17,38 m
21,10 m
Income tax expense
-3,50 m
-2,07 m
-1,21 m
229,63 k
Effective tax rate
-38,19%
-17,51%
-7,13%
0,94%
Other operating expenses
368,20 k
340,52 k
-202,15 k
1,03 m
Net income
12,65 m
13,90 m
18,17 m
24,14 m
Net profit margin
15,28%
19,05%
22,95%
27,85%
Earnings per share
-
-
-
-
Interest and investment income
4,10 m
4,34 m
5,18 m
3,80 m
Interest expense
-
-85,85 k
-112,57 k
-113,68 k
Net interest expenses
4,10 m
4,25 m
5,06 m
3,69 m
Depreciation and amortization charges
-
-
-
-
EBITDA
6,85 m
10,50 m
15,31 m
20,71 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google-programme